← Human Trials & Peer-Reviewed Studies

Effects of Zinc-Biofortified Wheat Intake on Plasma Markers of Fatty Acid Metabolism and Oxidative Stress Among Adolescents.

Plain-language guide to PMID 39770887 (2024): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
39770887
Journal
Nutrients
Year
2024
Study type
Randomized Controlled Trial
Authors
Shahzad B et al. (7 authors)
DOI
10.3390/nu16244265

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

Since plasma zinc concentration (PZC) does not reliably respond to small changes in zinc intake, biomarkers sensitive to small changes in zinc intake achievable though biofortification are needed.

Activity indices for zinc-dependent metabolic steps of desaturation and elongation of omega-6 fatty acids (FAs) have been proposed as sensitive zinc biomarkers.

Oxylipin metabolites of polyunsaturated FAs may also respond to changes in zinc intake and further mediate metabolic response to oxidative stress.

Who Took Part

The age groups tagged for this paper are children and teenagers, women only.

How the Study Was Run

The design is described as randomized and double-blind.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

Total plasma FAs and oxylipins were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS).

Activity indices were estimated from the ratios of product to precursor FAs.

What Was Measured

PubMed files the paper under topics including Oxidative Stress, Triticum, Zinc, Biomarkers, Fatty Acids, Pakistan and Food, Fortified.

The authors tagged it with the keywords biofortification, cardiometabolic health, fatty acid desaturation, oxylipins and plasma zinc concentration.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Nutrients), a journal based in Switzerland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.